KLAS THERAPEUTICS

At KLAS Therapeutics our mission is to revolutionise the treatment of melanoma skin cancer using our patentable KLAS technology... Thanks to KLAS Therapeutics PDT therapy can be used for the first time in the fight against malignant melanoma. Our patented technology allows PDT to target the melanoma cells with clinical studies showing 500% tumour size reduction compared to PDT alone and in vitro erradication of nearly 100% of melanoma cells... Melanoma cancer kills 57,000 people each year world wide, costing health services billions of dollars.